REMS AND OTHER DRUG DISTRIBUTION RESTRICTIONS: WHEN DOES A BRAND COMPANY HAVE A DUTY TO DEAL WITH ITS GENERIC RIVALS?
SPONSORED BY THE ANTITRUST SECTION AND FOOD, DRUG & COSMETIC LAW SECTION
November 3, 2016
6:00 to 9:00 pm (CLE panel followed by cocktails and hors d'oeuvres)
Debevoise & Plimpton LLP
919 Third Avenue
New York, NY 10022
1.5 NY MCLE credits in professional practice
*Please note that you must be a NYSBA member to join a section
Attendance is complimentary for anyone not requiring CLE credit.
Elinor R. Hoffmann, Office of the New York State Attorney General
Peter Safir, Covington & Burling LLP
Daniel W. Butrymowicz, Federal Trade Commission
Seth Silber, Wilson Sonsini Goodrich & Rosati
William Reiss, Robins Kaplan LLP, Moderator
Janet B. Linn, Bleakley Platt & Schmidt, LLP, Moderator
Co-sponsored by the Coordinated Conduct Committee and Class Action Committee of the Antitrust Law Section, and the Food, Drug and Cosmetic Law Section.
For more information about the Antitrust Section, please contact Tiffany Bardwell at email@example.com.